Merger Law Is Dante’s Inferno Revisited
The shift by agencies away from the current guidelines on mergers and acquisitions has left firms in limbo.
Jimmy Carter, The Great Deregulator
By pushing for deregulation and adopting other reforms, President Carter left an enduring legacy on the U.S. regulatory system.
FDA, Not a Federal Judge, Should Decide on Abortion Drugs
Anti-abortion advocates take aim at FDA approval and regulation of the abortion drug mifepristone, threatening access nationwide.
FDA Advances Program for Real-World Evidence
FDA’s approach to evidence-based decision-making may not be addressed to the right people.
Virginia Charts a Path Forward on Regulatory Modernization
New agency sets example for state and federal agencies to follow in analyzing regulatory costs and benefits.
Net-Zero Emission Pledges May Not Lead to Full Decarbonization
Examining countries’ net-zero pledges reveals variations and loopholes that will allow for slippage in climate progress.
Think Globally on Climate, Act Locally on Leaf Blowers
Restricting gas-powered leaf blowers can positively affect the health of people and the planet.
Control Over Litigation and Agency Rulemaking
Private rights of action lead agencies to seek greater policy control through rulemaking.
Public Opinion Supports Electric Vehicle Tax Credits
The U.S. public prefers electric vehicle tax credits be open to cars manufactured anywhere.
Could Financial Disclosures Curb Climate Change?
Climate disclosures—if designed well—can bridge the gap between financial actors and regulatory goals.
Noncompete Agreements and Antitrust’s Rule of Reason
The Federal Trade Commission should develop a nuanced approach to employee noncompete agreements.
DNA Testing is Not “Just Saliva”
To protect consumers, governments should step in to address the risks of DNA testing.